Načítá se...
Combining Epigenetic and Immune Therapy to Combat Cancer
The most exciting recent advance for achieving durable management of advanced human cancers is immune therapy, especially the concept of immune checkpoint blockade. However, with the exception of melanoma, most patients do not respond to immune therapy alone. A growing body of work has shown that ep...
Uloženo v:
| Vydáno v: | Cancer Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4873370/ https://ncbi.nlm.nih.gov/pubmed/26988985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-2125 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|